Resonant Therapeutics, Inc. — Form D
Resonant Therapeutics, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-26. The offering totals $2.0M, of which $1.2M was reported sold. Industry: Other.
Offering
- Filed: 2015-10-26
- Form: D
- Accession: 0001656695-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.2M
- Remaining: $810K
- Investors: 3
- Date of first sale: 2015-10-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-250055
Issuer
- Name: Resonant Therapeutics, Inc.
- CIK: 0001656695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2450 Holcombe Blvd., Houston, TX, 77021
- Phone: 925.389.8539
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| John K Westwick | Director | Houston, TX |
| John K Westwick | Executive Officer | Houston, TX |
| Dan K Watkins | Director | Houston, TX |
| Dan K Watkins | Executive Officer | Houston, TX |
Other filings by this issuer (2)
More